Skip to main content

FDA pharmacologic class

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor

5 medicines are in FDA's class of hepatitis b virus nucleoside analog reverse transcriptase inhibitors: entecavir (Baraclude), lamivudine (Epivir), tenofovir disoproxil (Viread), adefovir dipivoxil and tenofovir alafenamide (Vemlidy); 17 combination products also contain one. 11 of the 22 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is entecavir 0.5 mg tablet at $0.219 per tablet (NADAC).

Which medicines are hepatitis b virus nucleoside analog reverse transcriptase inhibitor?

Recalls: FDA enforcement reports, 2012 on
MedicineBrand namesGeneric labelers (all forms)Pharmacy costBoxed warningShortageRecalls since 2012
Emtricitabine and tenofovir disoproxilTruvada25 labelers$0.529 per tablet 200-300 mg tabletYesNo current entry1
EntecavirBaraclude15 labelers$0.219 per tablet 0.5 mg tabletYesNo current entry5
LamivudineEpivir14 labelers$0.489 per tablet 150 mg tabletYesNo current entry2
Tenofovir disoproxilViread15 labelers$0.294 per tablet 300 mg tabletYesNo current entry0
Lamivudine and zidovudineCombivir7 labelers$0.771 per tablet Lamivudine-zidovudine tabletYesNo current entry1
Efavirenz and emtricitabine and tenofovir disoproxilnone listed7 labelers$1.12 per tablet 600-200-300 mg tabletYesNo current entry0
Abacavir and lamivudinenone listed6 labelers$1.48 per unit 600-300 mgYesNo current entry0
Bictegravir and emtricitabine and tenofovir alafenamideBiktarvynone listed$136.73 per tablet 50-200-25 mg tabletYesNo current entry0
Efavirenz and lamivudine and tenofovir disoproxilSymfi1 labelern/aYesNo current entry0
Emtricitabine and rilpivirine and tenofovir disoproxilComplera2 labelers$114.50 per tablet 200-25-300 mg tabletYesNo current entry0
Abacavir and dolutegravir and lamivudineTriumeqnone listed$130.01 per tablet 600-50-300 mg tabletYesNo current entry1
Adefovir dipivoxilnone listed2 labelers$21.73 per tablet 10 mg tabletYesNo current entry0
Emtricitabine and tenofovir alafenamideDescovynone listed$74.94 per tablet 200-25 mg tabletYesNo current entry0
Abacavir and lamivudine and zidovudinenone listed1 labelern/aYesNo current entry0
Cobicistat, darunavir, emtricitabine and tenofovir alafenamideSymtuzanone listed$152.87 per tablet 800-150-200-10 mg tabletYesNo current entry0
Cobicistat, elvitegravir, emtricitabine and tenofovir alafenamideGenvoyanone listed$143.35 per tablet Genvoya tabletYesNo current entry0
Cobicistat, elvitegravir, emtricitabine and tenofovir disoproxilStribildnone listed$150.14 per tablet Stribild tabletYesNo current entry0
Dolutegravir and lamivudineDovatonone listed$105.22 per tablet 50-300 mg tabletYesNo current entry0
Doravirine and lamivudine and tenofovir disoproxilDelstrigonone listed$93.06 per tablet 100-300-300 mg tabletYesNo current entry0
Emtricitabine and rilpivirine and tenofovir alafenamideOdefseynone listed$130.49 per tablet Odefsey tabletYesNo current entry0
Lamivudine and tenofovir disoproxilCimduonone listedn/aYesNo current entry0
Tenofovir alafenamideVemlidynone listed$51.98 per tablet 25 mg tabletYesNo current entry0

Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What do pharmacies pay?

Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?